These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11001250)

  • 21. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine in the treatment of resistant depression.
    Caetano D; Caetano SC
    Aust N Z J Psychiatry; 2005; 39(1-2):108-9. PubMed ID: 15660713
    [No Abstract]   [Full Text] [Related]  

  • 23. Lower gastrointestinal bleeding and paroxetine use: two case reports.
    Blasco-Fontecilla H; de Leon J
    Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
    Yasui-Furukori N; Kaneko S
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is GSK guilty of fraud?
    Lancet
    Lancet; 2004 Jun; 363(9425):1919. PubMed ID: 15194246
    [No Abstract]   [Full Text] [Related]  

  • 27. [Paroxetine-induced neuroleptic malignant syndrome].
    Heinemann F; Assion HJ; Hermes G; Ehrlich M
    Nervenarzt; 1997 Aug; 68(8):664-6. PubMed ID: 9380213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitor. Discontinuation syndrome.
    Finfgeld DL
    J Psychosoc Nurs Ment Health Serv; 2002 Dec; 40(12):14-8. PubMed ID: 12491870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minor strokes related to paroxetine discontinuation in an elderly subject: emergent adverse events.
    Ramasubbu R
    Can J Psychiatry; 2003 May; 48(4):281-2. PubMed ID: 12776398
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic epidermal necrolysis after paroxetine treatment.
    Ahmed R; Eagleton C
    N Z Med J; 2008 May; 121(1274):86-9. PubMed ID: 18535650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
    Bryois C; Rubin C; Zbinden JD; Baumann P
    Praxis (Bern 1994); 1998 Mar; 87(10):345-8. PubMed ID: 9545842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unilateral facial numbness and visual blurring associated with paroxetine discontinuation.
    Strickland GM; Hough DW
    J Clin Psychopharmacol; 2000 Apr; 20(2):271-2. PubMed ID: 10770473
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
    Tanii H; Ichihashi K; Inoue K; Fujita K; Okazaki Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1176-8. PubMed ID: 16720068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paroxetine withdrawal syndrome in a neonate.
    Dahl ML; Olhager E; Ahlner J
    Br J Psychiatry; 1997 Oct; 171():391-2. PubMed ID: 9373435
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal convulsions secondary to paroxetine withdrawal.
    Ahmed M; Parameshwaran A; Swamy P
    J Pak Med Assoc; 2007 Mar; 57(3):162. PubMed ID: 17432029
    [No Abstract]   [Full Text] [Related]  

  • 38. Antidepressant withdrawal syndrome.
    Young AH; Currie A; Ashton CH
    Br J Psychiatry; 1997 Mar; 170():288. PubMed ID: 9229040
    [No Abstract]   [Full Text] [Related]  

  • 39. Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
    Haddad PM; Devarajan S; Dursun SM
    J Psychopharmacol; 2001 Jun; 15(2):139-41. PubMed ID: 11448088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of serial nightmares and oneiroid state under paroxetine for senile depression.
    Kobayashi T; Yamauchi M
    Psychogeriatrics; 2012 Mar; 12(1):54-7. PubMed ID: 22416829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.